期刊文献+
共找到18篇文章
< 1 >
每页显示 20 50 100
肥胖者血清脂联素水平与代谢状况的关系 被引量:13
1
作者 陈倩楠 伍丽 +1 位作者 朱益民 张旭慧 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2021年第6期778-782,共5页
目的调查肥胖者血清中常见细胞因子水平与其代谢状况的关系,初步探讨肥胖代谢异质性的分子机制。方法以浙江代谢综合征队列基线人群中代谢异常和代谢正常肥胖者为研究对象,采用Luminex方法检测其血清中脂联素、血管内皮生长因子A(VEGF-A... 目的调查肥胖者血清中常见细胞因子水平与其代谢状况的关系,初步探讨肥胖代谢异质性的分子机制。方法以浙江代谢综合征队列基线人群中代谢异常和代谢正常肥胖者为研究对象,采用Luminex方法检测其血清中脂联素、血管内皮生长因子A(VEGF-A)、干扰素-γ(IFN-γ)、胰岛素生长因子(IGF-1)、白细胞介素-6(IL-6)等细胞因子水平,比较各细胞因子水平在两组间的差异。结果代谢正常肥胖组血清脂联素水平的中位数为3.09μg/mL,四分位数间距(P;-P;)为2.00~4.48μg/mL,显著高于代谢异常肥胖组的2.31μg/mL(P_(25)-P_(75)为1.73~3.43μg/mL)(P=0.011)。其它细胞因子水平两组间差异无统计学意义(均P>0.05)。二元Logistic回归结果显示,高脂联素水平可以降低肥胖代谢异常的发生风险,OR值为0.25(95%CI:0.09~0.76,P=0.014);高脂联素水平也能降低高血压的发生风险,OR值为0.13(95%CI:0.04~0.45,P=0.001);与高三酰甘油血症也呈边缘性负相关,OR值为0.35(95%CI:0.12~1.04,P=0.059)。结论血清脂联素与肥胖的代谢状况有关,高脂联素水平会降低肥胖代谢异常风险。 展开更多
关键词 脂联素 肥胖 代谢异质性 高血压
下载PDF
Clear cell hepatocellular carcinoma: origin,metabolic traits and fate of glycogenotic clear and ground glass cells 被引量:6
2
作者 Peter Bannasch Silvia Ribback +1 位作者 Qin Su Doris Mayer 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2017年第6期570-594,共25页
Clear cell hepatocellular carcinoma(CCHCC)has hitherto been considered an uncommon, highly differentiated variant of hepatocellular carcinoma(HCC) with a relatively favorable prognosis. CCHCC is composed of mixtures o... Clear cell hepatocellular carcinoma(CCHCC)has hitherto been considered an uncommon, highly differentiated variant of hepatocellular carcinoma(HCC) with a relatively favorable prognosis. CCHCC is composed of mixtures of clear and/or acidophilic ground glass hepatocytes with excessive glycogen and/or fat and shares histology, clinical features and etiology with common HCCs. Studies in animal models of chemical, hormonal and viral hepatocarcinogenesis and observations in patients with chronic liver diseases prone to develop HCC have shown that the majority of HCCs are preceded by, or associated with, focal or diffuse excessive storage of glycogen(glycogenosis) which later may be replaced by fat(lipidosis/steatosis). In ground glass cells, the glycogenosis is accompanied by proliferation of the smooth endoplasmic reticulum, which is closely related to glycogen particles and frequently harbors the hepatitis B surface antigen(HBs Ag).From the findings in animal models a sequence of changes has been established, commencing with preneoplastic glycogenotic liver lesions, often containing ground glass cells, and progressing to glycogen-poor neoplasms via various intermediate stages, including glycogenotic/lipidotic clear cell foci, clear cell hepatocellular adenomas(CCHCA) rich in glycogen and/or fat, and CCHCC. A similar process seems to take place in humans, with clear cells frequently persisting in CCHCC and steatohepatitic HCC, which presumably represent intermediate stages in the development rather than particular variants of HCC. During the progression of the preneoplastic lesions,the clear and ground glass cells transform into cells characteristic of common HCC. The sequential cellular changes are associated with metabolic aberrations, which start with an activation of the insulin signaling cascade resulting in preneoplastic hepatic glycogenosis. The molecular and metabolic changes underlying the glycogenosis/lipidosis are apparently responsible for the dramatic metabolic shift from gluconeogenesis to the pentose ph 展开更多
关键词 clear cell hepatocellular carcinoma phenotypic heterogeneity GLYCOGENOSIS LIPIDOSIS preneoplastic glycogenosis progression metabolic aberrations
下载PDF
肿瘤微环境中细胞代谢相互作用的研究进展 被引量:1
3
作者 吴朋飞 杨智 +1 位作者 李青晏 王德年 《四川大学学报(医学版)》 CAS CSCD 北大核心 2024年第2期482-489,共8页
代谢重编程对肿瘤的发生和发展至关重要。肿瘤细胞的代谢及增殖受到细胞内在因素和肿瘤微环境(tumor microenvironment, TME)中代谢物的共同调节。TME中的代谢主要受到3个层面的调节:肿瘤代谢本身内在因素的调节;肿瘤细胞与T细胞、髓系... 代谢重编程对肿瘤的发生和发展至关重要。肿瘤细胞的代谢及增殖受到细胞内在因素和肿瘤微环境(tumor microenvironment, TME)中代谢物的共同调节。TME中的代谢主要受到3个层面的调节:肿瘤代谢本身内在因素的调节;肿瘤细胞与T细胞、髓系细胞、基质细胞之间代谢产物的相互影响;肿瘤细胞在组织空间中的代谢异质性。本文就肿瘤细胞不同的代谢调节模式进行了简要概述,并深入剖析了肿瘤细胞与TME中其他细胞的代谢相互影响,以及各类细胞的代谢特征和功能情况。这进一步为肿瘤的精准治疗提供了理论基础和新的思路。 展开更多
关键词 代谢重编程 肿瘤微环境 代谢异质性 糖酵解 代谢治疗 综述
原文传递
On-tissue chemical derivatization enables spatiotemporal heterogeneity visualization of oxylipins in esophageal cancer xenograft via ambient mass spectrometry imaging 被引量:3
4
作者 Jialin Liu Qingce Zang +7 位作者 Xinzhu Li Xinyi Tu Ying Zhu Lingzhi Wang Zitong Zhao Yongmei Song Ruiping Zhang Zeper Abliz 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第11期238-242,共5页
On-tissue chemical derivatization(OTCD)effectively enhances ionization efficiency of low abundant and poorly ionized functional molecules to improve detection sensitivity and coverage of mass spectrometry imaging(MSI)... On-tissue chemical derivatization(OTCD)effectively enhances ionization efficiency of low abundant and poorly ionized functional molecules to improve detection sensitivity and coverage of mass spectrometry imaging(MSI).Combination OTCD and MSI provides a novel strategy for visualizing previously undisclosed metabolic heterogeneity in tumor.Herein,we present a method to visualize heterogeneous metabolism of oxylipins within tumor by coupling OTCD with airflow-assisted desorption electrospray ionization(AFADESI)-MSI.Taking Girard’s P as a derivatization reagent,easily ionized hydrazide and quaternary amine groups were introduced into the structure of carbonyl metabolites via condensation reaction.Oxylipins,including 127 fatty aldehydes(FALs)and 71 oxo fatty acids(FAs),were detected and imaged in esophageal cancer xenograft with AFADESI-MSI after OTCD.Then t-distributed stochastic neighbor embedding and random forest were exploited to precisely locate the distribution of oxylipins in heterogeneous tumor tissue.With this method,we surprisingly found almost all FALs and oxo FAs significantly accumulated in the core region of tumor,and exhibited a gradual increase trend in tumor over time.These results reveal spatiotemporal heterogeneity of oxylipins in tumor progression,highlighting the value of OTCD combined with MSI to gain deeper insights into understanding tumor metabolism. 展开更多
关键词 On-tissue chemical derivatization Ambient mass spectrometry imaging OXYLIPINS Esophageal cancer metabolic heterogeneity
原文传递
重视基于代谢异质性的糖尿病视网膜病变早期诊断和精准防治研究 被引量:4
5
作者 张芳 许迅 《中华实验眼科杂志》 CAS CSCD 北大核心 2022年第1期1-5,共5页
糖尿病是多病因引起的慢性代谢性疾病,糖尿病视网膜病变(DR)是糖尿病的主要眼部并发症,是导致工作年龄人群不可逆盲的代谢性眼病。目前全球糖尿病患病率明显增加,且因DR早期导致的眼底血管神经单元病变无明显体征而常常延误诊疗,故DR的... 糖尿病是多病因引起的慢性代谢性疾病,糖尿病视网膜病变(DR)是糖尿病的主要眼部并发症,是导致工作年龄人群不可逆盲的代谢性眼病。目前全球糖尿病患病率明显增加,且因DR早期导致的眼底血管神经单元病变无明显体征而常常延误诊疗,故DR的早期诊断和防控面临着巨大挑战。现阶段DR的早期临床预测指标具有较好的预测和防控DR发生发展的价值,如糖化血红蛋白和血糖,但仍缺乏对糖尿病代谢异质性及其潜在诱发DR的病理作用研究。代谢组等多组学研究方法及深度学习技术是研究疾病病理生理过程的有力工具,可用于阐明DR的代谢特征,是发现早期生物标志物、代谢新途径和确立防治靶点的重要抓手。未来的DR诊疗应注重遗传背景和环境因素导致的患者代谢重塑诱发DR,将疾病发生和发展的临床指标测定与组学数据分析方法相结合,发现可预警DR早期发病的生物标志物和干预靶点,实现DR的早期预测和精准防控。 展开更多
关键词 糖尿病视网膜病变 代谢组学 生物标志物 代谢异质性 预防和治疗 靶点
下载PDF
大鼠骨关节组织的敞开式质谱成像分析方法研究
6
作者 朱时雨 李婷 +2 位作者 臧清策 张瑞萍 再帕尔·阿不力孜 《质谱学报》 EI CAS CSCD 北大核心 2024年第6期739-747,I0001,共10页
哺乳动物骨关节代谢异常与风湿性关节炎、类风湿性关节炎和骨关节炎等多种疾病密切相关。因此,研发适用于骨关节组织中代谢物可视化分析的质谱成像方法,对于深入理解生理病理条件下骨关节组织不同微区的代谢特征具有重要意义。本文采用... 哺乳动物骨关节代谢异常与风湿性关节炎、类风湿性关节炎和骨关节炎等多种疾病密切相关。因此,研发适用于骨关节组织中代谢物可视化分析的质谱成像方法,对于深入理解生理病理条件下骨关节组织不同微区的代谢特征具有重要意义。本文采用空气动力辅助解吸电喷雾离子化质谱成像(airflow-assisted desorption electrospray ionization-mass spectrometry imaging,AFADESI-MSI)技术,以代谢物的检出数量、响应强度和成像效果为主要评价指标,通过对骨关节组织样品切片制备方法、切片厚度和喷雾溶剂系统进行优化,建立了大鼠骨关节组织的敞开式质谱成像分析方法。考察相邻的6张大鼠膝关节组织切片,代表性代谢物响应强度的相对标准偏差均小于20%,表明该方法的重复性良好。进一步采用该方法对大鼠膝关节组织进行空间分辨代谢组学分析,发现骨质中磷酸戊糖途径、乙醛酸和二羧酸酯代谢、TCA循环等代谢通路更为显著;骨髓中抗坏血酸代谢与嘌呤代谢通路更为显著;软骨中精氨酸、脯氨酸代谢以及赖氨酸降解等氨基酸代谢通路更为显著。上述结果表明,大鼠膝关节组织不同微区具有明显的代谢异质性。本文建立的AFADESI-MSI方法适用于大鼠骨关节组织分析,为骨关节组织的代谢研究提供了可视化分析的技术手段。 展开更多
关键词 骨关节组织 质谱成像(MSI) 空间分辨代谢组学 代谢异质性
下载PDF
^(18)F-FDG PET/CT代谢参数和代谢异质性与胃癌患者人表皮生长因子受体2表达状态的相关性 被引量:2
7
作者 王建林 史爱琪 +3 位作者 范丑丑 王育珠 郭国蓉 柳江燕 《中国医学科学院学报》 CAS CSCD 北大核心 2022年第4期628-635,共8页
目的探讨^(18)F-FDG PET/CT代谢参数及代谢异质性对预测胃癌患者HER2表达状态的价值。方法回顾性分析2016年9月至2021年5月45例经手术病理证实的胃癌患者临床资料,所有患者术前均行^(18)F-FDG PET/CT检查,分别测量胃癌原发灶的最大标准... 目的探讨^(18)F-FDG PET/CT代谢参数及代谢异质性对预测胃癌患者HER2表达状态的价值。方法回顾性分析2016年9月至2021年5月45例经手术病理证实的胃癌患者临床资料,所有患者术前均行^(18)F-FDG PET/CT检查,分别测量胃癌原发灶的最大标准摄取值(SUVmax)、肿瘤代谢体积(MTV)及总病变糖酵解量,并计算不同SUVmax阈值(40%×SUVmax、80%×SUVmax)对应的MTV之间的线性回归斜率,将斜率的绝对值视为原发灶的代谢异质性,即异质性指数(HI),采用单因素和多因素Logistic回归分析评估^(18)F-FDG PET/CT代谢参数及HI与HER2表达的相关性。结果45例患者中HER2表达阳性10例、阴性35例。MTV(P=0.043)及HI(P=0.048)在HER2表达阳性患者中明显低于HER2表达阴性患者,差异有统计学意义。MTV及HI最佳阈值分别为12.10 cm^(3)及3.71,其预测HER2表达的准确性分别为62.2%及57.8%。单因素分析显示肿瘤的分化程度、MTV及HI与HER2表达相关,多因素Logistic回归分析显示仅肿瘤的分化程度(OR=20.130,95%CI=1.843~219.860,P=0.014)是HER2表达的独立预测因素。对肿瘤分化程度进一步分层分析显示,在中/高分化胃癌中,HER2表达状态仅在不同MTV阈值组间差异有统计学意义(P=0.031)。结论MTV及HI与胃癌HER2的表达相关,但均无法起到独立预测作用,需结合患者临床病理特征,用以辅助指导治疗方案的选择。 展开更多
关键词 胃癌 ^(18)F-FDG PET/CT 代谢参数 代谢异质性 人表皮生长因子受体2
下载PDF
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity 被引量:2
8
作者 Partha Pal Rajan Palui Sayantan Ray 《World Journal of Hepatology》 2021年第11期1584-1610,共27页
Non-alcoholic fatty liver disease(NAFLD)is a heterogeneous condition with a wide spectrum of clinical presentations and natural history and disease severity.There is also substantial inter-individual variation and var... Non-alcoholic fatty liver disease(NAFLD)is a heterogeneous condition with a wide spectrum of clinical presentations and natural history and disease severity.There is also substantial inter-individual variation and variable response to a different therapy.This heterogeneity of NAFLD is in turn influenced by various factors primarily demographic/dietary factors,metabolic status,gut microbiome,genetic predisposition together with epigenetic factors.The differential impact of these factors over a variable period of time influences the clinical phenotype and natural history.Failure to address heterogeneity partly explains the sub-optimal response to current and emerging therapies for fatty liver disease.Consequently,leading experts across the globe have recently suggested a change in nomenclature of NAFLD to metabolic-associated fatty liver disease(MAFLD)which can better reflect current knowledge of heterogeneity and does not exclude concomitant factors for fatty liver disease(e.g.alcohol,viral hepatitis,etc.).Precise identification of disease phenotypes is likely to facilitate clinical trial recruitment and expedite translational research for the development of novel and effective therapies for NAFLD/MAFLD. 展开更多
关键词 Non-alcoholic fatty liver disease metabolic-associated fatty liver disease heterogeneity PHENOTYPES NOMENCLATURE Clinical trial Effective therapies
下载PDF
Mass Spectrometry and Mass Spectrometry Imaging-based Thyroid Cancer Analysis 被引量:2
9
作者 Hao-Jiang Wang Bo Li +5 位作者 Meng-Ting Zhang Chao-Fan Chai Xiao-Rong Li Ning Li Hong Xiao Wei Bian 《Journal of Analysis and Testing》 EI 2022年第3期235-246,共12页
Thyroid carcinoma is one of the most common endocrine malignant diseases worldwide.With the rapid development of medical technology,early and effective diagnostic methods could be able to improve the survival rate and... Thyroid carcinoma is one of the most common endocrine malignant diseases worldwide.With the rapid development of medical technology,early and effective diagnostic methods could be able to improve the survival rate and quality of life of patients suffering from the disease.Considering the complexity of cancer,some specific detection method is desired for diagnosis and treatment.Mass spectrometry imaging(MSI)is an emerging technique for acquiring molecular information from biological tissues without staining and labeling,including qualitative,quantitative and spatial distribution information.Over the past several decades,MSI has been widely used for pharmacological monitoring,biomolecular imaging of cells and tissues.In this review,we introduce the tumor progression and histological characteristics of thyroid cancer,and focus mainly on the preparation of biological specimens for MSI and mass spectrometry(MS)analysis,as well as the recent progress in MS and MSI-based thyroid cancer research.This review thoroughly discusses the importance of MS and MSI for clinical diagnosis,identification and prognosis of thyroid cancer,and provides some new clues for molecular mechanisms research and tumor metastasis. 展开更多
关键词 Thyroid cancer metabolic heterogeneity Mass spectrometry imaging Mass spectrometry Tumor biomarker
原文传递
Classification of metabolic-associated fatty liver disease subtypes based on TCM clinical phenotype 被引量:1
10
作者 Chenxia Lu Hui Zhu +1 位作者 Mingzhong Xiao Xiaodong Li 《Gastroenterology & Hepatology Research》 2023年第1期6-12,共7页
Objective:To classify the subtypes of metabolic-associated fatty liver disease(MAFLD)and provide new insights into the heterogeneity of MAFLD.Methods:Electronic medical records(EMR)of MAFLD diagnosed in accordance wit... Objective:To classify the subtypes of metabolic-associated fatty liver disease(MAFLD)and provide new insights into the heterogeneity of MAFLD.Methods:Electronic medical records(EMR)of MAFLD diagnosed in accordance with the diagnostic criteria of Hubei Provincial Hospital of Traditional Chinese Medicine from 2016-2020 were included in the study.for physical annotation,and the data on each clinical phenotype was normalized according to corresponding aspirational standards.The MAFLD heterogeneous medical record network(HEMnet)was constructed using sex,age,disease diagnosis,symptoms,and Western medicine prescriptions as nodes and the co-occurrence times between phenotypes as edges.K-means clustering was used for disease classification.Relative risk(RR)was used to assess the specificity of each phenotype.Statistical methods were used to compare differences in laboratory indicators among subtypes.Results:A total of patients(12,626)with a mean age of 55.02(±14.21)years were included in the study.MAFLD can be divided into five subtypes:digestive diseases(C0),mental disorders and gynecological diseases(C1),chronic liver diseases and decompensated complications(C2),diabetes mellitus and its complications(C3),and immune joint system diseases(C4).Conclusions:Patients with MAFLD experience various symptoms and complications.The classification of MAFLD based on the HEMnet method is highly reliable. 展开更多
关键词 metabolic-associated fatty liver disease electronic medical records disease classification heterogeneous medical record network disease heterogeneity
下载PDF
Integrative analysis of bulk and single-cell RNA sequencing data reveals distinct subtypes of MAFLD based on N1-methyladenosine regulator expression
11
作者 Jinyong He Cuicui Xiao +2 位作者 Cuiping Li Fan Yang Cong Du 《Liver Research》 CSCD 2023年第2期145-155,共11页
Background:Metabolic dysfunction-associated fatty liver disease(MAFLD)is now the most prevalent chronic liver disease worldwide,with an increasing incidence rate.MAFLD is a heterogeneous disease that can have a low or... Background:Metabolic dysfunction-associated fatty liver disease(MAFLD)is now the most prevalent chronic liver disease worldwide,with an increasing incidence rate.MAFLD is a heterogeneous disease that can have a low or high-risk profile for developing severe liver disease in its natural course.Recent evidence has highlighted the critical role of RNA methylation modification in the pathogenesis of various liver diseases.However,it remains unclear whether the RNA N1-methyladenosine(m1A)modification of immune cells could potentially contribute to the pathogenesis and heterogeneity of MAFLD.Materials and methods:To address this issue,we conducted an integrated bioinformatics analysis of MAFLD bulk and single-cell RNA sequencing(scRNA-seq)data to pinpoint m1A regulators in the network.This was followed by a description of the immune landscape,pathway enrichment analysis,and molecular subtyping.Results:The expression patterns of m1A regulatory genes stratify MAFLD into two molecular subtypes,Cluster 1 and Cluster 2.These subtypes demonstrate different immune cell infiltration with distinct inflammation characteristics,which suggest different immune-inflammatory responses in the liver.Notably,Cluster 2 is associated with pro-inflammation and may be more likely to lead to progressive stages of MAFLD.Through intersection analysis of weighted gene co-expression network analysis(WGCNA)and m1A regulatory genes,three true hub genes(ALKBH1,YTHDC1,and YTHDF3)were identified,all of which were strongly correlated with infiltrating immune cells.The specific signaling pathways involved in the three core genes were derived from genomic variation analysis.Furthermore,scRNA-seq data from 33,168 cells from six liver samples identified 26 cell clusters and eight cell types,with endothelial cells,macrophages,and monocytes showing the most significant differences between MAFLD and normal controls.The cell-cell communication network between immune cells and nonparenchymal cells was extremely sophisticated and changed significantly in MAFLD. 展开更多
关键词 metabolic dysfunction-associated fatty liver disease(MAFLD) N1-methyladenosine(m1A)RNA METHYLATION Immune cell infiltration Inflammation Disease heterogeneity
原文传递
Metabolic heterogeneity of gastric cancer cell lines
12
作者 Xia-xia FAN Ying-li ZHU +5 位作者 Bei-bei SHAO Lu-lu LI Ya-fei LI Ao JIA Ai-feng WANG Yong-cheng MA 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2018年第4期278-279,共2页
OBJECTIVE Gastric cancer is one of the most common malignant tumors,and the incidence rate is the highest in all kinds of tumors in China.However,it remains unclear that how signifi.cantly gastric cells are dependent ... OBJECTIVE Gastric cancer is one of the most common malignant tumors,and the incidence rate is the highest in all kinds of tumors in China.However,it remains unclear that how signifi.cantly gastric cells are dependent on glycolysis,and which type of gastric cells are sensitive to glycolysis inhibition.In this study,several kind of gastric cancer cell lines were used as the research object,and the metabolic characteristics of different cell lines were systematically analyzed to provide theoretical support for the accurate treatment of gastric cancer.METHODS We examined the energy metabolism of four gastric cancer cell lines(MGC-803,SGC-7901,HGC-27 and BGC-823) by using glycolysis inhibitor,2-deoxy-D-glucose(2-DG) and inhibitor of oxidative phosphorylation,oligomycin.Oxygen consumption rates(OCR) and L-lactate were also measured with an XF96 Analyzer(Seahorse Biosciences) to deter.mine the significance of metabolism of oxidative phosphorylation and aerobic glycolysisin gastric cells.In addition,western blot was used to detect the contribution of AMP-activated protein kinase(AMPK),and anti-apoptotic proteins(Bcl-2 and survivin) to clarify the mechanism of death or survival of gastric cancer cells treated by 2-DG or oligomycin.RESULTS In this study,it was shown that the growth of gastric cell lines were suppressed by 2-DG.However,the sensitivity to 2-DG was quite different among cell lines:IC 50 of 2-DG was from 3.28 mmol·L^(-1)(MGC-803) to 15.57 mmol·L^(-1)(BGC-823).MGC-803 was relatively sensitive to 2-DG(IC 50:3.28 mmol·L^(-1)),consumed more glucose and produced more lactate(waste product of glycolysis) than the three other cell lines.Consequently,MGC-803 could be more dependent on glycolysis than other cell lines,which was further confirmed by the fact that glucose(+) FCS(-) medium showed more growth and survival than glucose(-) FCS(+) medium.Alternatively,BGC-823,most resistant to 2-DG(IC50:15.57 mmol · L-1),was most sensitive to oligomycin,and showed more growth and survival in glucose(-) FCS(+) medium than 展开更多
关键词 胃癌 恶性肿瘤 治疗方法 临床分析
下载PDF
高尿酸血症与代谢性疾病的民族异质性分析
13
作者 苗蕾 张弘炎 +3 位作者 姚华 孙玉萍 木斯林.苏克尔拜 史惠 《兵团医学》 2012年第3期41-44,共4页
目的研究新疆地区不同民族人群高尿酸血症与代谢性疾病的相关性。方法调查三民族人群2396例,血清检测血尿酸(SUA)及血脂、血糖等相关生化指标,对所有调查对象进行常规体格检查。结果三民族血尿酸水平为汉族高于维吾尔族,更高于哈萨克族... 目的研究新疆地区不同民族人群高尿酸血症与代谢性疾病的相关性。方法调查三民族人群2396例,血清检测血尿酸(SUA)及血脂、血糖等相关生化指标,对所有调查对象进行常规体格检查。结果三民族血尿酸水平为汉族高于维吾尔族,更高于哈萨克族;在代谢性疾病相关指标间的比较,差异均有统计学意义;维吾尔族与高尿酸血症密切相关的疾病为高血脂、高血糖及肥胖(P<0.01);哈萨克族与高尿酸血症密切相关的疾病为高血压、高血脂及肥胖(P<0.01);而汉族高尿酸血症与高血压、高血脂、高血糖及肥胖疾病的相关性均有统计学意义(P<0.05)。结论高尿酸血症与代谢性疾病密切相关,新疆维、哈、汉族高尿酸血症与代谢性疾病间的关系存在民族异质性,为预防高尿酸血症的发生及不同民族高尿酸血症及相关代谢性疾病的诊治提供依据。 展开更多
关键词 高尿酸血症 代谢性疾病 新疆(维吾尔族 哈萨克族 汉族) 异质性
原文传递
陕西省城市成年人群肥胖代谢表型异质性流行病学特征分析 被引量:9
14
作者 景慧 滕雨芯 +5 位作者 Samuel Steven Chacha 石国帅 李晶 杜玉娇 颜虹 党少农 《中国公共卫生》 CSCD 北大核心 2022年第5期610-613,共4页
目的了解陕西省城市成年人群肥胖代谢表型异质性的流行特征,为肥胖代谢表型的个体分层化识别和分类管理提供可靠依据。方法收集2017—2019年中国西北区域自然人群队列研究陕西城市队列基线调查中13072名20~89岁无重大疾病城市成年人群... 目的了解陕西省城市成年人群肥胖代谢表型异质性的流行特征,为肥胖代谢表型的个体分层化识别和分类管理提供可靠依据。方法收集2017—2019年中国西北区域自然人群队列研究陕西城市队列基线调查中13072名20~89岁无重大疾病城市成年人群的相关数据,以肥胖和代谢异常状况区分人群的肥胖代谢亚型为代谢健康型非肥胖(MHNO)、代谢不健康型非肥胖(MUNO)、代谢健康型肥胖(MHO)和代谢不健康型肥胖(MUO),对比分析不同肥胖代谢表型人群的异质性及流行病学特征。结果陕西省13072名城市成年人群中,MHNO者8700人(66.55%),MUNO者2949人(22.56%),MHO者535人(4.09%),MUO者888人(6.79%)。在男性人群中,MHNO、MUNO、MHO和MUO者比例分别为55.8%、27.9%、6.1%和10.2%,肥胖代谢表型随年龄的增加而变化(χ^(2)_(趋势)=9.143,P_(趋势)=0.002);MUNO的比例随年龄的增加而上升(χ^(2)_(趋势)=217.096,P_(趋势)<0.001),NHNO和MHO的比例均随年龄的增加而下降(均P_(趋势)<0.001)。在女性人群中,MHNO、MUNO、MHO和MUO者比例分别为55.8%、27.9%、4.09%和6.79%,肥胖代谢表型随年龄的增加而变化(χ^(2)_(趋势)=486.235,P_(趋势)<0.001);MUNO、MHO和MUO的比例均随年龄的增加而上升(均P_(趋势)<0.05),NHNO的比例随年龄的增加而下降(χ^(2)_(趋势)=738.600,P_(趋势)<0.001)。当肥胖标准从BMI≥28变为BMI≥25时,MHO的比例从4.09%增加至16.06%;当代谢异常标准从≥2项指标异常变为≥0项指标异常时,MHO的比例从4.09%降低至1.02%。结论陕西省城市成年人群肥胖代谢异质性明显,存在肥胖且代谢正常的人群但比例较低,而肥胖人群的代谢异常问题较为突出。 展开更多
关键词 肥胖代谢表型 异质性 流行病学特征 成年人群 城市
原文传递
2016年和2019年新疆维吾尔自治区博州不同人群肥胖代谢表型异质性变化分析 被引量:1
15
作者 丘佳琪 任俊名 +2 位作者 何雪 潘懿 王全 《中国预防医学杂志》 CAS CSCD 2024年第3期330-337,共8页
目的 了解新疆维吾尔自治区(新疆)博州成人肥胖代谢表型异质性情况,探讨在不同性别和年龄人群中肥胖代谢表型分布变化情况,为有针对性地选择加强干预的人群提供依据。方法 收集2016年与2019年新疆博州参与全民健康体检的成年人群相关数... 目的 了解新疆维吾尔自治区(新疆)博州成人肥胖代谢表型异质性情况,探讨在不同性别和年龄人群中肥胖代谢表型分布变化情况,为有针对性地选择加强干预的人群提供依据。方法 收集2016年与2019年新疆博州参与全民健康体检的成年人群相关数据,根据体质量指数(body mass index,BMI)和血压、空腹血糖、三酰甘油和高密度脂蛋白胆固醇4个代谢指标,综合判定体质量和代谢情况,将研究对象分为代谢正常非肥胖(metabolically healthy non-obesity, MHNO)、代谢异常非肥胖(metabolically unhealthy non-obesity, MUNO)、代谢正常肥胖(metabolically healthy obesity, MHO)和代谢异常肥胖(metabolically unhealthy obesity,MUO)。采用配对t检验和配对χ2检验分析2016年与2019年博州不同性别和年龄人群BMI、代谢情况和肥胖代谢表型分布差异性。结果 2016年博州5 484名成人的肥胖代谢表型分布为MHNO者1 460例(26.62%),MUNO者2 690例(49.05%),MHO者282例(5.14%),MUO者1 052例(19.18%);2019年为MHNO者1 387例(25.29%), MUNO者2 702例(49.27%), MHO者288例(5.25%),MUO者1 107例(20.19%)。在不同性别中,男性2019年MUNO者与MUO者的比例高于2016年(MUNO:56.86%vs. 53.48%;MUO:20.76%vs. 20.43%;χ^(2)=13.753,P=0.033);女性2019年MHO者与MUO者的比例高于2016年(MHO:7.21%vs.6.27%;MUO:19.70%vs.18.12%;χ^(2)=25.814,P<0.01)。在不同年龄段中,18~<40岁人群2016年与2019年肥胖代谢表型分布的差异无统计学意义(χ^(2)=5.229,P=0.515);40~<60岁人群2019年MHNO者与MHO者的比例高于2016年(MHNO:38.05%vs.32.02%;MHO:8.06%vs.7.53%;χ^(2)=19.459,P=0.003);≥60岁人群2019年MUNO者与MUO者的比例高于2016年(MUNO:58.59%vs.55.43%;MUO:21.99%vs.20.01%;χ^(2)=48.949,P<0.01)。结论 新疆博州成人肥胖代谢表型较为稳定,但肥胖代谢异质性明显。不同性别和年龄人群的肥胖代谢表型随时间变化存在差异。 展开更多
关键词 肥胖代谢表型 异质性 体检数据
原文传递
非酒精性脂肪性肝病更名:从代谢功能障碍相关脂肪肝异质性到“同病异治” 被引量:1
16
作者 刘嘉玲 孙劲晖(审校) 《中国中西医结合消化杂志》 CAS 2024年第5期450-454,共5页
关于非酒精性脂肪性肝病(NAFLD)更名为代谢功能障碍相关脂肪肝(MAFLD/MASLD)近两年来争议不断,期间大数据研究结果证明了NAFLD的时代局限性。重新审视命名法,可以正确认识NAFLD关键致病因素、了解其异质性及不同临床表型。目前NAFLD药... 关于非酒精性脂肪性肝病(NAFLD)更名为代谢功能障碍相关脂肪肝(MAFLD/MASLD)近两年来争议不断,期间大数据研究结果证明了NAFLD的时代局限性。重新审视命名法,可以正确认识NAFLD关键致病因素、了解其异质性及不同临床表型。目前NAFLD药物疗法临床应答率不高,通过分析其异质性,结合中医“同病异治”理论为临床诊断、研究、治疗NAFLD提供参考。 展开更多
关键词 非酒精性脂肪性肝病 代谢性脂肪肝疾病 异质性 同病异治
原文传递
根治性放化疗前^(18)F-FDG PET/CT代谢异质性参数结合临床特征对食管鳞状细胞癌预后的预测价值
17
作者 马希雅 季虎 +3 位作者 朱泽华 潘博 谢强 姚晓波 《实用医学杂志》 CAS 北大核心 2024年第7期966-971,共6页
目的探讨根治性放化疗(D-CRT)前^(18)F-FDG PET/CT代谢和异质性参数结合临床特征对食管鳞状细胞癌(ESCC)患者预后的预测价值。方法回顾性分析接受D-CRT的106例ESCC患者的临床资料,所有患者在治疗前均接受了^(18)F-FDG PET/CT检查,通过... 目的探讨根治性放化疗(D-CRT)前^(18)F-FDG PET/CT代谢和异质性参数结合临床特征对食管鳞状细胞癌(ESCC)患者预后的预测价值。方法回顾性分析接受D-CRT的106例ESCC患者的临床资料,所有患者在治疗前均接受了^(18)F-FDG PET/CT检查,通过数据处理获得肿瘤原发灶的代谢和异质性参数。随访所有患者的总生存期。采用Kaplan-Meier法和Cox比例风险模型分析患者临床特征、肿瘤代谢和异质性参数与患者预后的关系。结果所有患者1、1.5年总生存率分别为77.4%、51.9%,中位生存时间为20个月。单因素分析表明:N分期、M分期、肿瘤代谢体积、病灶糖酵解总量、异质性指数-2(HI-2)、40%最大标准化摄取值为阈值的变异系数(CV40%)与ESCC预后相关(P<0.05)。多因素分析表明:N分期、CV40%是ESCC患者预后的独立危险因素(P=0.039、<0.001)。结论N分期、肿瘤代谢异质性参数CV40%与ESCC D-CRT患者的预后密切相关,并具有一定的预测价值。 展开更多
关键词 食管鳞状细胞癌 肿瘤内代谢异质性 调强放疗 PET/CT 预后
下载PDF
从非酒精性脂肪性肝病到代谢性脂肪性肝病——基于疾病异质性角度的分析 被引量:3
18
作者 林思岑 冯巩 +2 位作者 刘军林 严琴琴 弥曼 《临床肝胆病杂志》 CAS 北大核心 2020年第11期2597-2600,共4页
非酒精性脂肪性肝病(NAFLD)已成为全球第一大慢性肝病,然而目前没有批准的药物用于临床实践。由于NAFLD本身异质性等原因,虽然药物疗法正在开发中,但应答率似乎不高。为了满足临床试验设计和为药物开发者提供准确信息等需要,相关学者建... 非酒精性脂肪性肝病(NAFLD)已成为全球第一大慢性肝病,然而目前没有批准的药物用于临床实践。由于NAFLD本身异质性等原因,虽然药物疗法正在开发中,但应答率似乎不高。为了满足临床试验设计和为药物开发者提供准确信息等需要,相关学者建议将NAFLD改名为代谢性脂肪性肝病(MAFLD)。总结了NAFLD异质性的来源以及NAFLD更名的背景,从而为新治疗方法的研发提供新的思路。 展开更多
关键词 非酒精性脂肪性肝病 代谢性脂肪性肝病 异质性
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部